Target intelligence / Profile preview

CHD1 divergent transcript (CHD1-DT)

Target
CHD1-DT
Molecular classification
Other, Long non-coding RNA (lncRNA)
01

Overview

CHD1 divergent transcript (CHD1-DT), also known as LOC100289230, is an uncharacterized human gene annotated in genomic databases. The term "divergent transcript" suggests it is a non-coding RNA (likely a lncRNA) transcribed in proximity to the CHD1 (chromodomain helicase DNA-binding protein 1) gene, but not encoding the CHD1 protein. There are no available data linking CHD1-DT to therapeutic mechanisms, drug interaction, or established roles in disease, and its biological function remains undefined in peer-reviewed literature[2]. Notes & clarifications: - There is substantial information on the protein-coding gene CHD1[1][5], a chromatin remodeler with roles in transcription, chromatin modification, and certain developmental and stem cell processes. However, CHD1 divergent transcript is a distinct, non-coding gene with no known target or effector function. - The term "divergent transcript" often refers to non-coding or regulatory RNA located near and transcribed in the opposite direction from a known gene (here, CHD1), but such loci are usually not drug targets unless specific function is proven. In summary, CHD1-DT/LOC100289230 is not a current therapeutic or functional target, and is likely listed due to its genomic proximity and divergent transcription relative to the protein-coding CHD1 gene. There is no data supporting a role as a target, biomarker, or involvement in disease.

Other names
LOC100289230CHD1 divergent transcriptCHD1-DT
02

Biological functions

Unknown
03

Disease associations

Unknown

Beyond the preview

Go deeper on CHD1 divergent transcript (CHD1-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CHD1 divergent transcript (CHD1-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call